Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis

Local Institution - 0051, Kew Gardens

Local Institution - 0005, Pittsburgh

Local Institution - 0011, Mahlow

Local Institution - 0048, Hamburg

Local Institution - 0022, Rockville

Local Institution - 0006, Norfolk

Local Institution - 0012, Lübeck

Local Institution - 0040, Romans-sur-Isère

Local Institution - 0026, Krakow

Local Institution - 0041, Louisville

Local Institution - 0007, Indianapolis

Local Institution - 0047, Bloomfield Hills

Local Institution - 0002, New Brighton

Local Institution - 0038, Witten

Local Institution - 0013, Frankfurt am Main

Local Institution - 0001, Hot Springs

Local Institution - 0019, Paris

Local Institution - 0044, Rouen

Local Institution - 0033, Houston

Local Institution - 0004, San Antonio

Local Institution - 0003, Portland

Local Institution - 0008, Beverly

Local Institution - 0049, East Windsor

Local Institution - 0017, Lodz

Local Institution - 0014, Rzeszów

Local Institution - 0015, Wroclaw

Local Institution - 0031, London

Local Institution - 0045, Salford

Local Institution - 0039, Southampton